Georg Lenz is Head of the Translational Oncology Unit at the University Hospital in Münster, Germany. He started his career in Munich, Germany in 2002 and completed a fellowship at the National Cancer Institute in Bethesda, USA. In 2009, he moved to Berlin and continued his scientific career as Professor of Molecular Pathogenesis of Malignant Lymphomas at the Charité – Universitätsmedizin Berlin, where he also worked as an attending physician at the Medical Clinic of Hematology, Oncology and Tumor Immunology until 2014. Professor Lenz’s research focuses on the molecular characterization of lymphomas. His research team is currently studying signaling pathways that are responsible for lymphoma development. Clinically, he focuses on trials investigating the efficacy of novel compounds in the therapy of patients with hematological malignancies. Professor Lenz has published more than 70 articles in peer-reviewed journals such as the New England Journal of Medicine, Science, Nature, Blood, and the Journal of Clinical Oncology, and he has authored several books and book chapters.
You can see my upcoming and previous webinars here.